user

DEALS BOOM IN OFF-PATENT AG CHEMICALS

被引：0
|
作者：
Reisch, Marc
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2014年 / 92卷 / 43期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [21] Competition in off-patent drug markets:: Issues, regulation and evidence
    Kanavos, Panos
    Costa-Font, Joan
    Seeley, Elizabeth
    Zweimueller, Josef
    ECONOMIC POLICY, 2008, (55) : 500 - 544
  • [22] Federal Spending on Off-Patent Drugs That Lack Generic Competition
    Rome, Benjamin N.
    Kesselheim, Aaron S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (03) : 821 - 823
  • [23] THE IMPACT OF REGIONAL LEGISLATIVE MEASURES ON THE PRESCRIPTION OF OFF-PATENT MEDICINES
    Tettamanti, A.
    Urbinati, D.
    Tucci, C.
    VALUE IN HEALTH, 2016, 19 (07) : A446 - A446
  • [24] Governments, off-patent vaccines, smallpox and universal childhood vaccination
    Music, Stanley
    VACCINE, 2010, 28 (04) : 869 - 872
  • [25] Generic versions launched as Viagra ((R)) goes off-patent
    Sklan, Alexandra
    PHARMACEUTICAL PATENT ANALYST, 2013, 2 (05) : 582 - 582
  • [26] Dynamics of price competition in Italian pharmaceutical off-patent market
    Perna, Serena
    Cangini, Agnese
    Marini, Roberto
    Guerrizio, Maria Alessandra
    Da Cas, Roberto
    Traversa, Giuseppe
    Trotta, Francesco
    FRONTIERS IN MEDICINE, 2022, 9
  • [27] Federal Spending on Off-Patent Drugs That Lack Generic Competition
    Benjamin N. Rome
    Aaron S. Kesselheim
    Journal of General Internal Medicine, 2021, 36 : 821 - 823
  • [28] MARKET UPTAKE MODELS OF BIOSIMILARS AND OFF-PATENT BIOLOGICAL MEDICINES
    Moorkens, E.
    Meuwissen, N.
    Huys, I
    Vulto, A.
    Declerck, P.
    Simoens, S.
    VALUE IN HEALTH, 2016, 19 (07) : A452 - A452
  • [29] Policy options for sustainable access to off-patent antibiotics in Europe
    Dimitra Panteli
    Michael Anderson
    Thomas Fieldman
    Enrico Baraldi
    Thomas Tängdén
    Sabine Vogler
    Christine Årdal
    Elias Mossialos
    npj Antimicrobials and Resistance, 2 (1):
  • [30] Nifedipine labeling illustrates the pediatric dilemma for off-patent drugs
    Adcock, KG
    Wilson, JT
    PEDIATRICS, 2002, 109 (02) : 319 - 321
12345